bpc-157 human trial dosage clinical trials BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 TB500 peptides: complete guide
Description
For peptides you plan to use within weeks, refrigeration is adequate

Can I overdose

Its prime features include uncompromised sterility, high peptide purity, and a user-friendly packaging that ensures product integrity

Quick and easy, very user friendly Great so far